$ALDR ALDER BIOPHARMACEUTICALS INC Insider Trading Week 22/2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALDER BIOPHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALDER BIOPHARMACEUTICALS INC in week 22/2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | M | 1.27 | 10,000 | 12,650 | 38,181 | |
| Jun 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 30.26 | 1,965 | 59,460 | 114,768 | 116.7 K to 114.8 K (-1.68 %) |
| Jun 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 29.51 | 8,035 | 237,084 | 116,733 | 124.8 K to 116.7 K (-6.44 %) |
| Jun 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Buy | M | 1.27 | 10,000 | 12,650 | 124,768 | 114.8 K to 124.8 K (+8.71 %) |
| Jun 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 1.65 | 10,000 | 16,500 | 53,636 | |
| Jun 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 30.02 | 10,000 | 300,216 | 242,200 | 252.2 K to 242.2 K (-3.97 %) |
| Jun 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 1.65 | 10,000 | 16,500 | 252,200 | 242.2 K to 252.2 K (+4.13 %) |
| Jun 02 2016 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | A | 29.26 | 15,000 | 438,900 | 15,000 | |
| Jun 02 2016 | ALDR | ALDER BIOPHARMACEU ... | Preston Heather | Director | Option Exercise | A | 29.26 | 15,000 | 438,900 | 15,000 | |
| Jun 02 2016 | ALDR | ALDER BIOPHARMACEU ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 29.26 | 15,000 | 438,900 | 15,000 | |
| Jun 02 2016 | ALDR | ALDER BIOPHARMACEU ... | Montgomery Alan Bruce | Director | Option Exercise | A | 29.26 | 15,000 | 438,900 | 15,000 | |
| Jun 02 2016 | ALDR | ALDER BIOPHARMACEU ... | DOW STEPHEN M | Director | Option Exercise | A | 29.26 | 15,000 | 438,900 | 15,000 | |
| Jun 02 2016 | ALDR | ALDER BIOPHARMACEU ... | Cleveland Paul B | Director | Option Exercise | A | 29.26 | 15,000 | 438,900 | 15,000 | |
| Jun 02 2016 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | A | 29.26 | 15,000 | 438,900 | 15,000 | |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 1.65 | 9,091 | 15,000 | 63,636 | |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 1.27 | 24,508 | 31,003 | 0 | |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 1.27 | 6,401 | 8,097 | 24,508 | |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 30.04 | 33,599 | 1,009,284 | 242,200 | 275.8 K to 242.2 K (-12.18 %) |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 1.65 | 9,091 | 15,000 | 275,799 | 266.7 K to 275.8 K (+3.41 %) |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 1.27 | 24,508 | 31,003 | 266,708 | 242.2 K to 266.7 K (+10.12 %) |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 30.05 | 6,401 | 192,335 | 242,200 | 248.6 K to 242.2 K (-2.57 %) |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 1.27 | 6,401 | 8,097 | 248,601 | 242.2 K to 248.6 K (+2.64 %) |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Option Exercise | M | 0.39 | 19,720 | 7,592 | 25,000 | |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Option Exercise | M | 0.39 | 5,280 | 2,033 | 44,720 | |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Sell | S | 30.05 | 19,720 | 592,566 | 74,567 | 94.3 K to 74.6 K (-20.91 %) |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Buy | M | 0.39 | 19,720 | 7,592 | 94,287 | 74.6 K to 94.3 K (+26.45 %) |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Sell | S | 30.06 | 5,280 | 158,693 | 74,567 | 79.8 K to 74.6 K (-6.61 %) |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Buy | M | 0.39 | 5,280 | 2,033 | 79,847 | 74.6 K to 79.8 K (+7.08 %) |